Enzymatica AB (ENZY):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Enzymatica AB (ENZY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8080
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Enzymatica AB (Enzymatica) is a life science company that develops and markets medical products for various virus and bacterial infections. The company offers mouth sprays and veterinary products. Its veterinary products comprise dental health and skin relief enzyme based gels, dental and dental spray gels, spray dermal and dermal gels, and others. Enzymatica’s mouth spray products are based on barrier technology which includes marine enzymes. The company’s veterinary products are used in gum and skin infection diseases, microbial adhesion, wound healing and dermatitis healing applications for dogs, cats and horses. It also develops new indications based on the ColdZyme formulation. The company sells its products across Sweden. Enzymatica is headquartered in Lund, Sweden.

Enzymatica AB (ENZY) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Enzymatica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enzymatica AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Enzymatica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enzymatica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Enzymatica AB, Medical Devices Deals, 2012 to YTD 2018 9
Enzymatica AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Enzymatica AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Enzymatica Enters into Distribution Agreement with Qualia Pharma 11
Enzymatica Enters into Distribution Agreement with STADA for ColdZyme 12
Enzymatica Enters into Distribution Agreement with Esteve 13
Equity Offering 14
Enzymatica to Raise USD11 Million in Rights Offering of Shares 14
Enzymatica Raises USD7.3 Million in Rights Offering of Shares 16
Enzymatica Completes Rights Offering Of Shares For US$3 Million 17
Acquisition 18
Enzymatica Acquires Zymetech for USD9 Million 18
Montpelier Nordic Acquires 5.26% Stake In Enzymatica, Biotech Company 20
Enzymatica AB – Key Competitors 21
Enzymatica AB – Key Employees 22
Enzymatica AB – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Apr 26, 2018: Enzymatica: Continued growth during the first quarter 24
Feb 14, 2018: Enzymatica: Strong growth and international breakthrough in 2017 25
Nov 01, 2017: Enzymatica: Sales soar in third quarter 27
Apr 20, 2017: Enzymatica: Breakthrough in Germany and continued increase in sales 28
Corporate Communications 29
Sep 06, 2017: Enzymatica recruits Chief Financial Officer 29
Jul 18, 2017: Enzymatica recruits Chief Commercial Officer 30
Jul 14, 2017: Enzymatica recruits Chief Operating Officer 31
Other Significant Developments 32
Jul 17, 2018: Enzymatica: Lower sales in Q2 but 31% increase for the first half of the year 32
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Enzymatica AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Enzymatica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enzymatica AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Enzymatica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enzymatica AB, Deals By Therapy Area, 2012 to YTD 2018 8
Enzymatica AB, Medical Devices Deals, 2012 to YTD 2018 9
Enzymatica AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Enzymatica Enters into Distribution Agreement with Qualia Pharma 11
Enzymatica Enters into Distribution Agreement with STADA for ColdZyme 12
Enzymatica Enters into Distribution Agreement with Esteve 13
Enzymatica to Raise USD11 Million in Rights Offering of Shares 14
Enzymatica Raises USD7.3 Million in Rights Offering of Shares 16
Enzymatica Completes Rights Offering Of Shares For US$3 Million 17
Enzymatica Acquires Zymetech for USD9 Million 18
Montpelier Nordic Acquires 5.26% Stake In Enzymatica, Biotech Company 20
Enzymatica AB, Key Competitors 21
Enzymatica AB, Key Employees 22
Enzymatica AB, Subsidiaries 23

List of Figures
Enzymatica AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Enzymatica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Enzymatica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Enzymatica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Enzymatica AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enzymatica AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Enzymatica AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enzymatica AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Enzymatica AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Enzymatica AB (ENZY):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • A2A SpA (A2A):企業の財務・戦略的SWOT分析
    A2A SpA (A2A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Powerco Ltd:企業の戦略的SWOT分析
    Powerco Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Raytheon Technologies Corp (RTX):企業の財務・戦略的SWOT分析
    Raytheon Technologies Corp (RTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Fulcrum Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Fulcrum Therapeutics Inc (Fulcrum Therapeutics) is a drug development company that focuses on the discovery and development of small molecule therapies to unlock the gene regulation in disease. The company’s pipeline products include Fragile X syndrome, Facioscapulohumeral muscular dystrophy …
  • XALT Energy LLC:企業の戦略的SWOT分析
    XALT Energy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Eurofins Scientific SE (ERF):企業の財務・戦略的SWOT分析
    Eurofins Scientific SE (ERF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Domtar Corporation:戦略・SWOT・企業財務分析
    Domtar Corporation - Strategy, SWOT and Corporate Finance Report Summary Domtar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • First Solar Inc (FSLR):企業の財務・戦略的SWOT分析
    First Solar Inc (FSLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Micell Technologies Inc:企業の製品パイプライン分析2018
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company provides product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to opt …
  • Enteris BioPharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Enteris BioPharma Inc (Enteris) is a biotechnology company that offers formulation solutions based on proprietary drug delivery technologies. The company’s product candidate includes oral leuprolide tablet, which is developed for endometriosis in women. Its other product candidates comprise …
  • Bioton SA (BIO):企業の戦略的SWOT分析
    Bioton SA (BIO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Russian Reinsurance Company
    Russian Reinsurance Company - Strategy, SWOT and Corporate Finance Report Summary Russian Reinsurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Muang Thai Life Assurance Public Company Limited:企業の戦略・SWOT・財務分析
    Muang Thai Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Muang Thai Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Genuine Parts Company:企業の戦略・SWOT・財務分析
    Genuine Parts Company - Strategy, SWOT and Corporate Finance Report Summary Genuine Parts Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Emisphere Technologies Inc (EMIS):企業の戦略的SWOT分析
    Emisphere Technologies Inc (EMIS) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Meyer Burger Technology AG (MBTN):企業の財務・戦略的SWOT分析
    Meyer Burger Technology AG (MBTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Healthscope Ltd (HSO):製薬・医療:M&Aディール及び事業提携情報
    Summary Healthscope Ltd (Healthscope) is an integrated healthcare provider that provides healthcare services through the ownership and management of hospitals and pathology laboratories. The company operates through private hospitals in Australia and pathology laboratories in New Zealand. It provide …
  • Equinor ASA (EQNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Equinor ASA (Equinor), formerly Statoil ASA, is an energy company. It focuses mainly on the exploration, development and production of crude oil and natural gas on the Norwegian Continental Shelf (NCS). The company also has operations in several of the important oil and gas provinces in the …
  • Laboratoire Aguettant SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoire Aguettant (Aguettant) is a pharmaceutical company that offers development, manufacturing and commercialisation of essential hospital medicines. The company offers products under various categories such as specialist sectors and delivery systems. Its speciality sector offers emerg …
  • Walmart Chile S.A.:企業の戦略的SWOT分析
    Walmart Chile S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆